The success of Mercy Research would not be possible without these key relationships.
“Our partnership with Mercy Research & Development has been pivotal in the success of Make People Better. The team at R&D adapted to the specific needs of my company, helping me to launch our cornerstone product, Re:iimmune, by providing connections to key opinion leaders and decision-makers. They have also been invaluable in gathering quantitative evidence of the benefits of the product, which has allowed me to more effectively market Re:iimune to clinicians and pharmacies. Mercy R&D has accelerated Make People Better and provided me with opportunities and support that I couldn’t have found anywhere else."
~Kerri Miller, Founder & CEO, Make People Better LLC
Missouri State University’s Jordan Valley Innovation Center operates under a mission of product development for their corporate partners and interdisciplinary educational experiences for students. The capabilities of the center include applied research in nanotechnology, bio-materials, advanced technologies, genomics/proteomics, bio-systems, software engineering and medical material device and instrument technologies. Mercy Research is a Senior Corporate Affiliate of JVIC which gives us access to a wide range of equipment, instrumentation, and expertise.
The eFactory is a technology-focused entrepreneurship center and business incubator designed to assist start-up and growth in new small businesses and continuing education and training in mature organizations. The eFactory houses several programs to accomplish these goals, including The eFactory Business Incubator, the Small Business and Technology Development Center, the Management Development Institute, Springfield Angel Network, Springfield Innovation, Inc, the Procurement Technical Assistance Center, Missouri Enterprise, and SCORE.
The Sprint Accelerator powered by Techstars is a three-month, immersive,mentorship-driven startup accelerator based in Kansas City, Missouri. The program helps startups build the future of mobile health that changes the world one patient or consumer at a time. Mercy Research has formed a partnership with this program and provides advisory support and for startups.
Cancer Research for the Ozarks (CRO) was founded in 1987 by a grant from the National Institute of Health, National Cancer Institute (NCI). In 2014, as the CCOP program ended CRO was selected to be one of only 34 community sites in the United States to participate in the NCI Community Oncology Research Program (NCORP). The overall goal of NCORP is to bring cancer clinical trials (cancer control, prevention, screening, treatment, and imaging), as well as cancer care delivery research (CCDR), to individuals in their own communities, thus generating a broadly applicable evidence base that contributes to improved patient outcomes and addresses health disparities and improves access to cancer care for under-served populations.
Quintiles applies the breadth and depth of its service offerings along with extensive therapeutic, scientific and analytics expertise to help its customers navigate an increasingly complex healthcare environment. Quintiles’ Product Development group enables biopharmaceutical R&D and medical device companies, government and non-government organizations, and generic and biosimilar customers outsource clinical development, from first-in-human studies to post-launch monitoring.
Make People Better LLC is the company behind re:iimmune™. The company is based in Springfield, Missouri. The company was founded by Dr. Kerri Miller. Her simple mission: Help make people better.
What is re:iimmune®?
re:iimmune® is an illness recovery formula. It combines:
This unique, dual-action formula helps support and fast-track your recovery from illness.